¾ÓÒ÷ÄÍ⶯ÂöÈë·µ¼¹ÜÒ©ºÐϵͳֲÈëÊõ¼°Ïà¹Ø½âÆÊѧ»ù´¡
ÀîÇ¿ ÉòµÏ Âí¿Ë¾´ ÎâÁú
¡¾ÕªÒª¡¿Ä¿µÄ ̽ÌÖ¾ÓÒ÷ÄÍ⶯Âö£¨RIEA£©Èë·µ¼¹ÜÒ©ºÐϵͳ£¨PCS£©Ö²ÈëÊõµÄ¿ÉÐÐÐÔ¡¢Ïà¹Ø½âÆÊѧ»ù´¡¼°ÊÖÊõ×¢ÒâÊÂÏî¡£·½·¨ 186ÀýÖÐÍíÆÚ¶ñÐÔÖ×Áö»¼ÕßÐÐRIEAÈë·PCSÖ²ÈëÊõ£»Ê¹ÓÃÊõºóÈë·¶¯ÂöÔìÓ°¼°Ê¬Ìå±ê±¾¾Ö²¿½âÆÊµÄ·½·¨Ñо¿ÒÔRIEAÔ¶¶Î´©´ÌµãΪÖÐÐĵÄÓÒ¸¹¹É¹µÇøÏà¹Ø½âÆÊ½á¹¹¡£½á¹û RIEA´©´Ì³É¹¦ÂÊ100%£¬PCSÖ²ÈëÊÖÊõ³É¹¦ÂÊ96.2%£¬²¢·¢Ö¢·¢ÉúÂÊ18.8%¡£PCSÖ²ÈëÊõºóÈë·¶¯ÂöÔìӰʾ£ºµ¼¹Ü½øÈëRIEAµÄλÖÃÔÚ¸¹±Ú϶¯ÂöÆðµãÉÏ·½Ô¼1¡«2cm´¦£»±ê±¾½âÆÊ×ܽá³öRIEAÈë·¿É´©´Ì¶Î¡¢´©´Ìµã¡¢ÓÒϸ¹±ÚÒ©ºÐÂñÖ²ÇøµÄ½âÆÊλÖü°´óÌå½âÆÊ½á¹¹¡£½áÂÛ ¾RIEAÈë·PCSÖ²ÈëÊõÊǰ²È«¿ÉÐе쬾ßÓÐÁ¼ºÃµÄ½âÆÊѧӦÓûù´¡£»ÕýÈ·ÕÆÎÕÊÊÓ¦Ö¢¼°´©´Ì¼¼Êõ£¬ÓÐÖúÓÚÌá¸ßÊÖÊõ³É¹¦ÂʺͼõÉÙ²¢·¢Ö¢¡£
¡¾¹Ø¼ü´Ê¡¿ ÷ÄÍ⶯Âö; ´©´Ì£»Ò©ºÐ; Ö²Èë; ½âÆÊѧ
Port catheter system implantation via right iliaca external artery and related anatomy
LI Qiang, SHEN Di, MA Ke-jing, WU Long
Department of Interventional Radiology, Wanjie Hospital, Zibo£¬Shandong Province 255213, China
¡¾Abstract¡¿ Objective To study the feasibility, related anatomy and announcements of port catheter system£¨PCS£© implantation via right iliaca external artery (RIEA). Methods PCS implantation Via RIEA were performed in 186 patients with malignant tumors. The related anatomy was studied by angiography of the right iliaca external arteries and local autopsy with 4 bodies. Results Success rate of RIEA puncture is 100%£¬Success rate of the PCS implantation is 96.2% , the complications were occurred in 35 cases£¨18.8%£©. The angiography of the right iliaca external arteries showed that the location catheters entered into was 1-2cm inferior to the orifice of epigastric artery. Puncture segment and point, location of PCS implantation and related anatomy were summarized by local autopsy. Conclusion PCS implantation via RIEA is safe and feasible. It has a favorable application base of anatomy. It is helpful controlling indication and mastering the puncture skill to increase the success rate and reduce the complications.
¡¾Key words¡¿ Artery , iliaca external; Puncture; Port catheter system; Implantation; Anatomy
²ÉÓýéÈë·½·¨µ¼¹ÜÒ©ºÐϵͳ(port catheter system, PCS)Ö²Èë½øÐг¤ÆÚÇøÓòÐÔ»¯ÁÆ/˨ÈûÒѳÉΪÖÎÁÆÖÐÍíÆÚ¶ñÐÔÖ×ÁöµÄÒ»ÖÖÓÐЧ·½·¨£¬µ«Æù½ñΪֹ£¬Èë·ÈÔ¶à²ÉÓÃ×óËø¹Ç϶¯Âö£¨left subclavicular artery, LSA£©¼°¹É¶¯Âö£¨femoral artery, FA£©£Û1-6£Ý¡£±ÊÕß×Ô1996ÄêÒÔÀ´£¬¾ÓÒ÷ÄÍ⶯Âö£¨right iliaca external artery, RIEA£©´©´Ì²å¹ÜÐÐPCSÖ²ÈëÊõ£¬²¢¶ÔÆäÏà¹Ø½âÆÊѧ»ù´¡¼°ÊÖÊõ×¢ÒâÊÂÏî½øÐÐÁËÑо¿ºÍ̽ÌÖ£¬±¨µÀÈçÏ¡£
²ÄÁÏÓë·½·¨
1.ÊÖÊõ²ÄÁϺͷ½·¨
186ÀýÖÐÍíÆÚ¶ñÐÔÖ×Áö»¼Õߣ¬ÄÐ 132Àý ,Å® 54Àý ,ÄêÁä23¡«79Ë꣬ƽ¾ùÄêÁä 52.7Ëê ,ÆäÖÐÔ·¢ÐԸΰ© 88Àý ,¸Î×ªÒÆÁö 79Àý£¬·Î°©9Àý£¬³¦¶ñÐÔÖ×Áö7Àý£¬ÅèÇ»¶ñÐÔÖ×Áö3Àý¡£»¯ÁÆÒ©ºÐΪ·¨¹úPfm¼°µÂ¹úBraun¼°ÃÀ¹úCOOK¹«Ë¾²úÆ·¡£
ÊÖÊõ·½·¨£¨Í¼1£©£ºÊ×ÏÈÐÐRIEA´©´Ì²å¹Ü£¬Æ¤·ô´©´ÌµãÔÚÓÒ¸¹¹É¹µÆ¤·ôÖåñÞÖе㣨÷Ä-¹É¶¯ÂöÒÆÐд¦£©ÉÏ·½2.5¡«3cm´¦£¨±ÈÊõÕßÄ´Ö¸ÂÔ¿í£©£¬´¥¼°÷ÄÍ⶯Âö²«¶¯ºó×ö¾ÖÂ飬ÓÚ²«¶¯µãÕýÉÏ·½ÏòÍ⣨ÏûÊÝÌåÖÊÕßÏòÄÚ£©×öºáÐÐ1cm³¤Æ¤·ôÇпڣ¬ÒÔֹѪǯ·ÖÀëdz½îĤ£¬Ê¹ÓÃ18Gǰ±Ú´©´ÌÕëÓÚÇпڿ¿ÄÚ²àRIEA²«¶¯µãÉÏ·½½øÕ룬´©´ÌÕëÆ«ÏòÍ·²à£¬ÓëÈËÌå¹Ú×´ÃæÔ¼³Ê60¡ã¡«70¡ã½Ç£¨Í¼2£©£¬²»Òª×óÓÒÇãб£¬ÕëβÓÐѪÅç³öºóËÍÈ볬»¬µ¼Ë¿£¬Í˳ö´©´ÌÕ룬ËÍÈë4F»ò5Fµ¼¹Ü½øÐвå¹Ü²Ù×÷¼°ÖÎÁÆ£¬ÖÎÁÆÍê±Ïºó½«ÁôÖõ¼¹ÜÔ¶¶ËÖÃÓڰж¯Âö£¬ÓÚ´©´ÌµãÉÏ·½µÄÓÒϸ¹£¨Óë´©´ÌµãÏà¾àÔ¼3 cm´¦£©¾ÖÂ飬×öÒ»Ô¼4cmµÄºáÐÐÆ¤·ôÇпڣ¨Óë´©´ÌµãÇÐ¿ÚÆ½ÐУ©£¬ÒÔֹѪǯ·ÖÀëÖÁdz½îĤÉºóÑØ¸¹Íâб¼¡ëìĤ±íÃæÏòÍ·²à·½Ïò×ö¶ÛÐÔ·ÖÀ룬×öÒ»Ö±¾¶Ô¼4cmµÄÄÒÇ»£¬ÓÃÑÎˮɴ²¼ÌîÈûÈëÄÒÇ»ÖÐÒÔѹÆÈ¿ÉÄܵijöѪ¡£ÌîÈûͬʱ£¬ÓÃֹѪǯ½«ÁôÖõ¼¹Üβ¶Ë¶àÓಿ·Ö¼ôÈ¥£¬È»ºó½«µ¼¹Ü¾Æ¤ÏÂÒýÖÁÄÒÇ»ÇпÚÄÚ²àÓëÒ©ºÐÔÚÇ»Íâ½ôÃÜÁ¬½Ó£¬PCSÊÔ×¢É䣬ȷÈÏÎÞÉøÂ©ºóÒÔ¸ÎËØÑÎË®·â±Õ¡£½«Ò©ºÐÖ²ÈëÄÒÇ»£¬×¢Òâ±£³ÖÆäµ×²¿Æ½Õû²¢ÔÚÒ©ºÐµÄÁ¬½Ó±ÛÉÏÓ÷ìÏ߹̶¨Ò»Õë¡£×îºóÒÀ´Î·ìºÏƤÏÂ×éÖ¯¼°Æ¤·ô£¬Óþƾ«É´²¼¸²¸Ç°üÔú¡£ÊÖÊõ½áÊø¡£
Êõºó´¦Àí£ºÊõºóÒ©ºÐ¼°´©´ÌµãÇпÚÓÃͬһɳ´üѹÆÈ6h£¬Æ½ÎÔ12h£¬¿¹ÉúËØÓ¦ÓÃ3¡«7Ì죬ÇпڸôÈÕ»»Ò©£¬7¡«10ÈÕ²ðÏß¡£PCS°ëÔÂÖÁÒ»Ô³åÏ´Ò»´Î£¬Ã¿¸ô1Ô»òÑ¡ÔñºÏÊÊʱ»ú¾PCSÐл¯ÁÆ»ò/ºÍ˨Èû¡£¾¹ýÊý´ÎÖÎÁƺóÈç¹û°ÐѪ¹ÜÒѱÕÈû¡¢µ¼¹ÜÒÆÎ»»ò²¡ÈËÒªÇóÈ¡³ýÕߣ¬µ÷Õû»òÈ¡³ýPCS¡£
2¡¢Ïà¹Ø½âÆÊѧ»ù´¡Ñо¿²ÄÁϺͷ½·¨
5ÀýPCSÖ²È뻼ÕßÊõºóÐÐÈë·¶¯Âö£¨RIEA£©ÔìÓ°ÒԹ۲쵼¹Ü½øÈëRIEAµÄ¾ßÌåλÖã»Ê¹ÓóÉÈËÄÐŮʬÌå±ê±¾¸÷2Àý£¬ÔÚÌå±í±ê¼Ç³öƤ·ô´©´ÌµãºÍÒ©ºÐÂñÖ²Çøºó×ö¾Ö²¿½âÆÊ£¬¹Û²ìÒÔRIEAÔ¶¶Î´©´ÌµãΪÖÐÐĵÄÓÒ¸¹¹É¹µÇøµÄ´óÌå½âÆÊ½á¹¹¡£
½á¹û
1.ÊÖÊõЧ¹û
186Àý»¼ÕßÈ«²¿Íê³ÉÓÒIEA´©´Ì²å¹Ü£¬´©´Ì³É¹¦ÂÊ100%£»179ÀýÍê³ÉPCSÖ²È룬ÊÖÊõ³É¹¦ÂÊ96.2%£¬µ¼¹ÜÔ¶¶ËÁôÖò¿Î»£º¸Î×ܶ¯ÂöÒÔÔ¶76Àý£¬Æ¢¶¯Âö48Àý£¬¸¹Ç»¸É¶¯Âö27Àý£¬³¦ÏµÄ¤É϶¯Âö¼°ÆðÔ´Óڴ˵ÄÃÔ×ßÓҸζ¯Âö»ò¸±ÓҸζ¯Âö17Àý£¬ÐØÖ÷¶¯Âö5Àý£¬÷ÄÄÚ¶¯Âöǰ¸ÉÒÔÔ¶3Àý£¬Ö§Æø¹Ü¶¯Âö3Àý£»PCSÖ²Èëʧ°Ü7Àý£¬ÆäÖÐ1ÀýÒò´©´Ì²å¹Ü¹ý³ÌÖд©´Ì²¿Î»Öð½¥Ðγɾ޴óѪÖ×£¬4Àý°ÐѪ¹Ü²å¹Ü²»³É¹¦£¬2ÀýÔìÓ°ºóÈÏΪÖ×ÁöµÄ¹©Ñª×´¿ö²»ÊʺÏPCSÖ²Èë¶ø·ÅÆú£»¾PCSÖÎÁÆ´ÎÊý1¡«11´Î £¬Æ½¾ù3.1´Î£»²¢·¢Ö¢¹²35Àý£¬·¢ÉúÂÊ18.8%£¬ÆäÖаÐѪ¹Ü±ÕÈû13Àý£¨7.0%£©£¬µ¼¹ÜÒÆÎ»11Àý£¨5.9%£©£¬´©´ÌµãѪÖ×7Àý£¨3.8%£©£¬PCSѪ˨ÐÔ±ÕÈû2Àý£¨1.1%£©£¬PCSµÄµ¼¹ÜÌåÍⲿ·Ö´òÕÛ2Àý£¨1.1%£©£¬Ò©ºÐÄÒÇ»ÄÚÉøÑª2Àý£¨1.1%£©£¬ÇпڸÐȾ1Àý£¨0.5%£©£¬ÓÒ²àØºÍèÕÍÍ´1Àý£¨0.5%£©¡£
2.½âÆÊѧ»ù´¡Ñо¿½á¹û
2.1 PCSÖ²ÈëÊõºóÈë·¶¯Âö£¨RIEA£©ÔìÓ°ÏÔʾ£ºµ¼¹Ü½øÈëRIEAµÄλÖÃÔÚÓÒ¸¹±Ú϶¯Âö£¨ÓÒ÷ÄÍ⶯Âö×îÄ©·ÖÖ§£©ÆðµãÉÏ·½Ô¼1¡«2cm´¦£¬´Ëµã´óÖÂÓë÷žÊÉÏÔµ»òÂÔ¸ßˮƽ£¨Í¼3£©¡£
2.2 ʬÌå±ê±¾¾Ö²¿½âÆÊ½á¹û
¢Ù RIEAÈ뷵Ŀɴ©´Ì¶Î£ºÎªÓÒ¸¹±Ú϶¯ÂöÆðµãÉÏ0.5¡«3cm³¤µÄÒ»¶Î£¬´Ë¶ÎRIEAλÖÃÏà¶Ô±ídz£¨Í¼4A¡¢B£©£¬ÖÜΧ±»¼¡½îĤºÍÏ·½µÄ¹ÉÇÊËù¹Ì¶¨£¬Òƶ¯¶ÈС£»¢Ú ´©´Ìµã£ºÆ¤·ô´©´ÌµãÔÚ¸¹¹É¹µÈÍ´øÉÏ·½2¡«2.5cm´¦£¬´©´ÌÕë½øÈëRIEAµÄλÖøßÓÚÆ¤·ô´©´Ìµã0.5¡«1cm£»´©´ÌµãˮƽµÄ½âÆÊ½á¹¹£¨Í¼5£©£ºÄÚ²àÓë÷ÄÍâ¾²ÂöÏàÁÙ£¬¶þÕ߯½ÐУ¬ÎÞÖØµþ»òÓÐÇá¶ÈÖØµþ£¬÷ÄÍâ¾²ÂöµÄÄÚ²àÓ븹ĤǻÏàÁÙ£¬ÄÚÓÐ䳦¡¢Ð¡³¦»ò°òë×£»Íâ²àÔÚ÷Ä¡¢Ñü¼¡ÏËά½»»ã´¦ÓйÉÉñ¾Í¨¹ý£¬ÓëRIEAÏà¾à½ÏÔ¶£»Ç°·½ÓÉÍâÖÁÄÚÒÀ´ÎΪ£ºÆ¤·ô¼°Ç³½îĤ-¸¹Íâб¼¡ëìĤ-¸¹ÄÚб¼¡¡¢¸¹ºá¼¡£¨ÓÐ2¾ß±ê±¾´Ë¼¡²ãÔÚ´©´ÌÈë·Äڲ࣬²»¾¹ý£©-¸¹ºá½îĤ£»ºó·½ÎªºñʵµÄ÷ÄÑü¼¡£»Ç°Ï·½ÔÚÓÒ¸¹±Ú϶¯ÂöÆðµãˮƽÓо«Ë÷£¨Å®Îª×Ó¹¬Ô²ÈÍ´ø£©ÏòÍâÈĹý÷ÄÍâѪ¹Ü¡£¢ÛÓÒϸ¹±ÚÒ©ºÐÂñÖ²ÇøÇ³²ã½âÆÊ½á¹¹£ºÓÉÍâÖÁÄÚÒÀ´ÎΪƤ·ô¼°Ç³½îĤ-¸¹Íâб¼¡ëìĤ-¸¹ÄÚб¼¡£¬Ò©ºÐ·ÅÖÃÔÚ¸¹Íâб¼¡ëìĤÉÏ·½µÄdz½îĤÄÚ£¬µ×²¿Îª¸¹Íâб¼¡ëìĤ¡£
ÌÖÂÛ
1.¾RIEAÈë·PCSÖ²ÈëÊõµÄ¿ÉÐÐÐÔÓë½âÆÊѧӦÓûù´¡
1.1 RIEAÈë·PCSÖ²ÈëÊõ´©´Ì´¦Ñª¹ÜÏà¶Ô±ídz£¬²«¶¯Ã÷ÏÔ£¬ÔÚÌå±íÒ×ÓÚ´¥Ãþ£¬ÇÒλÖù̶¨£¬»¬¶¯ÐÔС£¬ÊÊÒË´©´Ì¡£½âÆÊÉÏÆäǰ·½Îª½ÏÈíµÄ½îĤ²ã»ò/ºÍ·Æ±¡µÄ¼¡²ã£¬ÀûÓÚ½øÕ룻ºó·½ÎªºñʵµÄ÷ÄÑü¼¡£¬ÀûÓÚѹÆÈֹѪ£»ÄÚ²àÓë÷ÄÍâ¾²ÂöÖ®¼äÖØµþ¼¸Âʺͳ̶ÈС£¬²»Ò×Îó´©£»Íâ²àÓë¹ÉÉñ¾¾àÀëÏà¶Ô½ÏÔ¶£¬²»Ò×ËðÉË£¬ÕâЩ¶¼¶Ô´©´Ì²å¹ÜÓÐÀû£¬´ó´óÌá¸ßÁË´©´ÌµÄ³É¹¦ÂʺÍÊÖÊõ°²È«ÐÔ¡£¶øÒ©ºÐÂñÖ²ÔÚÓÒϸ¹£¬ÊÓÒ°¿ªÀ«£¬½âÆÊ²ã´ÎÇåÎú¡¢½á¹¹Æ½Õû£¬±ãÓÚÊÖÊõ½øÐкÍÒ©ºÐƽÎÈ·ÅÖá£ÁíÍ⣬ RIEA´©´Ì´©´ÌÄѶȵÍÓÚLSAÈë·£¬²¢ÇÒ±ÜÃâÁËÓÉ´©´ÌÒýÆðÑªÆøÐØµÈÑÏÖØ²¢·¢Ö¢Ê¹ÊÖÊõʧ°ÜµÄ¿ÉÄÜ£¬Ê¹ÊÖÊõ³É¹¦ÂÊÏà¶ÔÌá¸ß¡£±¾×éÊÖÊõ´©´Ì³É¹¦ÂÊ´ïµ½100%£¬ÊÖÊõ³É¹¦ÂÊ´ï96.2%£¬¸ßÓÚÎÄÏ×±¨µÀLSAÈë·£Û3£¬4£Ý£¬¶ø²¢·¢Ö¢·¢ÉúÂÊ18.8%£¬ÓëÎÄÏ×±¨µÀFAÈë·Ïà½ü£Û5£Ý£¬³ý1Àý¾Þ´óѪÖ×ÐγÉÍâÎÞÑÏÖØ²¢·¢Ö¢·¢Éú£¬È¡µÃÁËÁ¼ºÃµÄÁÙ´²Ð§¹û¡£¿É¼û£¬RIEA´©´ÌPCSÖ²ÈëÊõÊǰ²È«¿ÉÐе쬾ßÓÐÁ¼ºÃµÄ½âÆÊѧӦÓûù´¡¡£
1.2 ÔÚÁÙ´²ÎÄÏ×ÖУ¬ËäÈ»¹ØÓÚ÷ÄÍ⶯ÂöÈë·PCSÖ²ÈëµÄ±¨µÀÉÙ¼û£¬µ«ÓйØÓÚ¸ßλ¹É¶¯Âö´©´ÌÐÐÓÒϸ¹²¿PCSÖ²ÈëµÄ±¨µÀ£Û7-9£Ý£¬ÆäÖÐÓв¿·Ö±¨µÀµÄ´©´ÌµãλÓÚ¸¹¹É¹µÈÍ´øÉÏ·½£Û8£¬9£Ý£¬ÖÚËùÖÜÖª£¬÷ÄÍ⶯ÂöÊǾ¹ý¸¹¹É¹µÈÍ´øºóÒÆÐÐΪ¹É¶¯ÂöµÄ£¬ËùÒÔ¿ÉÒԿ϶¨ÕâЩ±¨µÀµÄÈë·ʵ¼ÊÉÏÊÇ÷ÄÍ⶯Âö¶ø·Ç¸ßλ¹É¶¯Âö£¬ÇÒ´©´ÌµãÒ²²»»áÌ«¿¿½ü¹É¶¯Âö,·ñÔò¼«Ò×ËðÉ˾«Ë÷µÈ½á¹¹£»Èç¹ûÕæµÄÊǸßλ¹É¶¯ÂöÈë·£¬ÁôÖõ¼¹ÜÏòÉϾƤϽøÈëÓÒϸ¹ÊƱؾ¹ý¸¹¹É¹µÈÍ´øÉÏ·½£¬¿ÉѹÆÈÈÍ´øÒýÆð»¼ÕߵĻ²»ÊÊ£¬ÇÒÑØÍ¾Ñ¹ÆÈ¾«Ë÷µÄ¿ÉÄÜÐÔÒ²½Ï´ó£¬ËùÒÔ×÷ÕßÈÏΪ´Ë·½·¨ÖµµÃÉÌȶ¡£
2. ¾RIEAÈë·PCSÖ²ÈëÊõµÄ×¢ÒâÊÂÏî
2.1ÕýÈ·ÕÆÎÕÊÊÓ¦Ö¢£¬Ô¤·À´©´ÌµãѪÖ×
±¾×éѪÖ×·¢ÉúÂÊ£¨3.8%£©¸ßÓÚFAÈë·£Û3£¬6£Ý£¬ÆäÖÐÒ»Àý¸ßÁä¸ßѪѹ»¼ÕßÔÚ²å¹Ü¹ý³ÌÖгöÏÖ¾Þ´óѪÖ×µ¼ÖÂÊÖÊõʧ°Ü¡£ÆäÔÒò³ýÁËÓë´©´Ì¶ÎѪ¹ÜÄÚѹÁ¦Ïà¶Ô½Ï¸ß¡¢´©´Ì½Ç¶È½Ï´ó¼°ÊõÕߵĴ©´ÌÊìÁ·³Ì¶ÈÏà¹ØÍ⣬×îÖ±½ÓµÄÒòËØÊÇ»¼Õß»¼Õß°éËæµÄ¶¯ÂöÓ²»¯¡¢¸ßѪѹ¡¢ÑÏÖØÄýѪ¹¦Äܲ»Á¼µÈ¼²²¡£¬±¾×鲡ÀýËùÓÐѪÖ׵ķ¢Éú¾ùÓë´ËÓйء£Òò´Ë£¬¾RIEAÈë·PCSÖ²ÈëÊõÓ¦°ÑÎÕºÃÊÊÓ¦Ö¢£¬ÓÐÑÏÖØ³öѪÇãÏò»ò¶¯ÂöÓ²»¯¡¢¸ßѪѹ»¼ÕßÓ¦ÁÐΪÏà¶Ô»ò¾ø¶Ô½û¼ÉÖ¢£Û1£Ý£¬ÕâÒ»µãÓ¦µ±Òý×ã¹»ÖØÊÓ¡£ÁíÍ⻹ӦÊìÁ·²Ù×÷£¬¼õÉÙ´©´Ì´ÎÊý£¬½µµÍѪÖ×·¢Éú¼¸ÂÊ¡£
2.2ÕýÈ·ÕÆÎÕ´©´Ì¼¼Êõ£¬±ÜÃâËðÉËÐÔ²¢·¢Ö¢·¢Éú
ÓÈÆäӦעÒâRIEAÈë·´©´ÌµãµÄλÖò»¿É¹ý¸ß»ò¹ýµÍ¡£ÔÚÄÐÐÔ£¬Æ¤·ô´©´ÌµãµÄÏ·½Ô¼0.5¡«1cm´¦Óо«Ë÷ÈĹý£¬´©´Ìµã¹ýµÍ¿ÉÄÜËðÉ˴˽ṹ£¬±¾×é¾ÍÓÐÒ»Àý»¼ÕßÊõºó³öÏÖÓÒ²àØºÍèÕÇÍ´£¬ÊýÔºóÖ¢×´Ïûʧ£¬Ó¦ÎªËðÉ˾«Ë÷ËùÖ¡£¶øÆ¤·ô´©´ÌµãµÄÉÏ·½Ô¼3ÀåÃ×ÒÔÉÏ£¬¸¹Ç»ÔàÆ÷Èç䳦»òС³¦¿ªÊ¼Öð½¥ÒÆÐÐÖÁRIEAµÄǰ·½£¬Èç´©´Ìµã¹ý¸ß»ò½øÕëʱÓë¹Ú×´Ãæ½Ç¶È¹ýСÓÐËðÉËÕâЩ½á¹¹µÄ¿ÉÄÜ£¬Òò´Ë´©´ÌʱƤ·ô´©´ÌµãλÖÃҪ׼ȷ£¬½øÕë½Ç¶ÈÒªÊʵ±£¬ÒÔ±ÜÃâËðÉËÐÔ²¢·¢Ö¢·¢Éú¡£
×ÜÖ®£¬¾RIEAÈë·PCSÖ²ÈëÊõÊǰ²È«¿ÉÐе쬾ßÓÐÁ¼ºÃµÄ½âÆÊѧӦÓûù´¡£»ÊìϤ´©´Ìµã½âÆÊ½á¹¹£¬ÕýÈ·ÕÆÎÕÊÖÊõÊÊÓ¦Ö¢¼°´©´Ì¼¼Êõ£¬ÓÐÖúÓÚÌá¸ßÊÖÊõ³É¹¦ÂʺͼõÉÙ²¢·¢Ö¢·¢Éú¡£
ͼ Ƭ

ͼ1 RIEAÈë·PCSÖ²ÈëÊÖÊõʾÒâͼ¡£A ´©´ÌµãÑ¡ÔÚÓÒ¸¹¹É¹µÆ¤·ôÖåñÞÖеãÉÏ·½2cm¡«2.5cm´¦¡£B µ¼¹ÜÁôÖÃÓڰж¯Âö¡£C Ò©ºÐÇпÚλÓÚÓÒϸ¹Óë´©´ÌµãÉÏÍâ·½Ïà¾àÔ¼3 cm´¦¡£

ͼ2 RIEA´©´Ì½Ç¶ÈʾÒâͼ¡£´©´ÌÕëÆ«ÏòÍ·²à£¬ÓëÈËÌå¹Ú×´ÃæÔ¼³Ê60¡ã¡«70¡ã½Ç¡£
ͼ3 RIEA Èë·PCSÖ²ÈëÊõºóÈë·¶¯Âö£¨RIEA£©ÔìÓ°¡£ÏÔʾµ¼¹ÜÔÚÓÒ÷žÊÉÏÔµÂÔ¸ßˮƽ¡¢ÓÒ¸¹±Ú϶¯ÂöÆðµã£¨ºÚ¼ý£©ÉÏ·½Ô¼1cm´¦½øÈëÓÒIEA£¨°×¼ý£©£¬µ¼¹Üβ¶ËתÏòÄÚÉÏÓëÒ©ºÐÁ¬½Ó£¬¡£
ͼ4A ÄÐÐԱ걾RIEA´©´Ìµã£¨ÓÒ÷žÊÉÏÔµÂԸߣ©Ë®Æ½MRI¶ÏÃæ½âÆÊͼ¡£¼ýͷʾ´Ö´ó±ídzµÄRIEA¼°ÆäÖÜΧ½á¹¹¡££¨Òý×Ô¡¶Ó°Ïñ¶Ï²ã½âÆÊѧ¡·. ÕÅÑ©ÁÖ, Ö÷±à. ±±¾©£ºÈËÃñÎÀÉú³ö°æÉ磬2000, 373.£©
ͼ4B Å®ÐԱ걾RIEA´©´Ìµã£¨ÓÒ÷žÊÉÏÔµ£©Ë®Æ½MRI¶ÏÃæ½âÆÊͼ¡£¼ýͷʾRIEA¼°ÆäÖÜΧ½á¹¹¡££¨Òý×Ô¡¶Ó°Ïñ¶Ï²ã½âÆÊѧ¡·. ÕÅÑ©ÁÖ, Ö÷±à. ±±¾©£ºÈËÃñÎÀÉú³ö°æÉ磬2000, 395.£©

ͼ5 RIEA´©´Ìµã²ãÃæ¶ÏÃæ½âÆÊʾÒâͼ¡£1¹ÉÉñ¾ 2 RIEA 3ÓÒ÷ÄÍâ¾²Âö 4dz½îĤ 5¸¹Ö±¼¡ 6С³¦ 7Ö±³¦ 8β¹Ç 9ÍÎ´ó¼¡ 10¹É¹ÇÍ· 11÷Ä¹Ç 12÷ÄÑü¼¡ 13¸¹ÄÚб¼¡¡¢¸¹ºá¼¡¡£
²Î ¿¼ ÎÄ Ï×
£Û1£Ý ÀîÑåºÀ£¬ÂÞÅô·É£¬»ÆÐÅ»ª£¬µÈ.¾Æ¤Ëø¹Ç϶¯Âöµ¼¹ÜÒ©ºÐϵͳֲÈëÊõ£ÛJ£Ý.Öлª·ÅÉäѧÔÓÖ¾£¬1995£¬29£¨8£©£º551-553.
£Û2£Ý Kuroiwa T , Honda H , Yoshimitsu K , et al. Complications encountered with a trasfemorally placed port-catheter system for hepatic artery chemotherapy infusion£ÛJ£Ý. Cardiovasc Intervent Radiol , 2001,24£¨1£©:90-93.
£Û3£ÝÖ쿵˳£¬ºú¹ú¶°£¬µ¥ºè£¬µÈ. ¾²»Í¬¾¶Â·¸Î¶¯ÂöÄÚÖ²ÈëÒ©ºÐµ¼¹ÜϵͳµÄ¶ÔÕÕÑо¿£ÛJ£Ý. ÁÙ´²·ÅÉäѧÔÓÖ¾£¬1999£¬18£¨5£©£º302-304.
£Û4£Ý³ÂÓ£¬ÀîÑåºÀ£¬µ¥ºè£¬µÈ. ¾Æ¤Ëø¹Ç϶¯Âöµ¼¹ÜÒ©ºÐϵͳֲÈëÊõµÄ²¢·¢Ö¢¼°´¦Àí£ÛJ£Ý. Öлª·ÅÉäѧÔÓÖ¾£¬1997£¬31£¨8£©£º540-541.
£Û5£ÝлСÎ÷, ºú¹ú¶°. ¾Æ¤¹É¶¯Âöµ¼¹ÜÒ©ºÐϵͳֲÈëÊõµÄ²¢·¢Ö¢¼°ÁÙ´²´¦Àí£ÛJ£Ý. ½éÈë·ÅÉäѧÔÓÖ¾£¬2004£¬13£¨5£©£º425-427.
£Û6£ÝºúµÀÓ裬ºú¹ú¶°£¬Ö쿵˳£¬µÈ. ¾Æ¤¹Édz¶¯ÂöÈë·ҩºÐÖ²ÈëÊõ²¢·¢Ö¢¼°´¦Àí£ÛJ£Ý.ÁÙ´²·ÅÉäѧÔÓÖ¾£¬1999£¬18£¨4£©£º234-235.
£Û7£Ý½ªéF,Ìï»áÃú, ÂÀ´óÀÍ,µÈ. ³¬Ñ¡ÔñÐÔ¶¯ÂöÄÚÖ²Èëµ¼¹ÜÒ©ºÐÏµÍ³ÇøÓòÐÔ¶¯Âö¹à×¢½éÈëÖÎÁÆÂÄÚ¶ñÐÔÖ×ÁöµÄÑо¿£ÛJ£Ý. ½éÈë·ÅÉäѧÔÓÖ¾£¬2000£¬9£¨1£©£º41-42.
£Û8£Ý¸ßÍòÇÚ,ÀîÔÆ¶«,³ÂµÇÍ¥£¬µÈ.¸ÄÁ¼·¨Ö²Èëʽµ¼¹ÜÒ©ºÐϵͳµÄÁÙ´²Ó¦ÓãÛJ£Ý. ʵÓ÷ÅÉäѧÔÓÖ¾ ,2001,17(2):147-148.
£Û9£Ý»Æ¹úöΣ¬ñ¼ÓÀ³ä£¬²ÜÂúÈ𣬵È. ¾Æ¤¹É¶¯Âö´©´ÌÓÒϸ¹Èë·ҩ ºÐÒ©ºÐÂñÖ²ÊõÖÎÁÆÍíÆÚ¸Î°©µÄÁÙ´²Ó¦ÓãÛJ£Ý. ½éÈë·ÅÉäѧÔÓÖ¾£¬2003£¬ 12£¨4£©£º304-305.
TAG: ´©´Ì ÷ÄÍ⶯Âö Ò©ºÐ Ö²Èë ½âÆÊѧ







